<DOC>
	<DOC>NCT02193048</DOC>
	<brief_summary>The purpose of this study is to prospectively evaluate a scoring system to predict a mild course of disease in patients newly diagnosed with Crohn's disease.</brief_summary>
	<brief_title>Prospective Evaluation of a Scoring System in Patients Newly Diagnosed With Crohn's Disease</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>All patients with Crohn's disease who have been newly diagnosed (initial diagnosis not more than 6 weeks previously) and are as yet untreated (permitted medications are a maximum of 10 days of 5aminosalicylates (5ASA) or glucocorticosteroids and antibiotics for nonintestinal indications) and have consented to the documentation of their patient data and agree to the up to 5year documentation of the course of disease Pretreatment with 5ASA &gt; 10 days Treatment with steroids &gt; 10 days Treatment with antibiotics, immunosuppressants or biological agents &gt; 10 days</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>